Akin advised Pharmakon Advisors on the deal. Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry, announced its $450 million financing commitment...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here